Previous studies showed that SPAG5 overexpression can predict poor prognosis in lung cancer and cervical cancer [9–11] and alter sensitivity to taxol treatment via the mTOR signaling pathway in cervical cancer [11]. This evidence concerns the gene MTOR and cervical carcinoma.